drugset / Trial / NCT06416735

Natriuretic Effect of Amiloride in Relation to the Alpha Adducin Gene (ADD-AMI) RS4961 Variant

NCT06416735

Phase 3 Completed 40 enrolled Ospedale San Raffaele
Non-randomizedParallel-groupOpen-labelOther

Summary

The study is a non-pharmacological interventional, single-center, national, non-randomised, comparative and open label.

Timeline

Start
2018-09-28
Primary completion
2020-07-20
Completion
2020-07-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Amiloride Small molecule 5 mg Oral
Subject Amiloride Small molecule 10 mg Oral